Physician profile
Jay U Patel
NPI 1740279009
$5,743.06
in general payments reported to CMS, 2019-2025
8 companies · $96.19 in 2025
The $96.19 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $771 · 2021: $201 · 2022: $3,012 · 2023: $462 · 2024: $124 · 2025: $96.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,651.25 | 2021-2023 | Ellipsys Vascular Access System |
| Philips North America LLC | $1,754.70 | 2019-2023 | |
| Cardiovascular Systems INC. | $714.00 | 2020 | |
| Bard Peripheral Vascular, INC. | $306.66 | 2019-2024 | Fluency Endovascular Stent Graft |
| Cardiva Medical, INC. | $153.97 | 2022-2025 | Cardiva Vascade 5f Vcs |
| Abbott Laboratories | $100.00 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $42.92 | 2023 | Invega Sustenna |
| Cook Medical LLC | $19.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.